Larry Douglas Altstiel's most recent trade in ProMIS Neurosciences Inc. was a trade of 165,000 Option (right to buy) done . Disclosure was reported to the exchange on Sept. 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ProMIS Neurosciences Inc | Larry Douglas Altstiel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2025 | 165,000 | 165,000 | - | - | Option (right to buy) | |
| ProMIS Neurosciences Inc | Larry Douglas Altstiel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2024 | 175,000 | 175,000 | - | - | Option (right to buy) |